Objective: To explore whether Human T-cell leukemia virus type I (HTLV-I) directly infects salivary gland epithelial cells (SGECs) and induces the niche of Sjögren's syndrome (SS).
INTRODUCTION
Human T-cell leukemia virus type I (HTLV-I) is reported to be one of the causative agents of primary Sjögren's syndrome (pSS) in endemic areas including Nagasaki City, Japan (1-3). The extremely high prevalence of SS found in patients with HTLV-I-associated myelopathy (HAM) appears to confirm a strong relationship between HTLV-I infection and SS (4-6). Our previous study also revealed the clinical characteristics of anti-HTLV-I antibody-positive SS patients, and we found that the labial salivary glands (LSGs) of such patients are not destructible compared to the LSGs of anti-HTLV-I antibody-negative SS patients (7). In addition, the low appearance of ectopic germinal center (GC) as well as the low expression of C-X-C motif chemokine 13 (CXCL13) in infiltrating mononuclear cells of LSGs were found as an immunohistological characteristic of anti-HTLV-I antibody-positive SS patients (8).
HTLV-I preferentially infects T cells, especially CD4+ T cells, and our findings described above indicated that the T-cell lineage may primarily contribute to the pathogenesis of anti-HTLV-I antibody-positive SS patients.
However, the cell types other than T cells, including the human retinal pigment epithelial cell line ARPE-19 (9) and human primary fibroblast-like synovial cells H. Nakamura et al. Here we investigated whether HTLV-I infects human primary salivary gland epithelial cells (SGECs) and modulates the production of functional molecules.
PATIENTS AND METHODS

Patients
H. Nakamura et al.
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Primary SGECs from LSGs were obtained from fifteen patients with primary SS diagnosed according to the revised criteria proposed by the American-European Consensus Group (12). All fifteen patients were female (age: 53.2 ± 15.4) in whom anti-HTLV-I antibody measured by a chemiluminescent enzyme immunoassay (CLEIA) was negative.
Antibodies and reagents
Mouse anti-HTLV-I (p19, p28, and GAG) antibody (Chemicon International, Temecula, CA, USA), mouse anti-NF-κB p65 antibody, mouse anti-cytochrome Monoclonal mouse anti-human CD4, CD8, CD20cy, mouse IgG1 and monoclonal rabbit anti-human cytokeratin 8/18 antibody were purchased from Dako Cytomation (Glostrup, Denmark).
LSGs biopsy and cell culture
We performed a biopsy of the LSGs from each patient's lower lip under local anesthesia and divided the samples into specimens for the diagnosis of sialadenitis by hematoxylin staining and the culture of SGECs in a defined keratinocyte-serum-free medium (SFM) culture medium (Invitrogen Life Technologies, Carlsbad, CA) supplemented with hydrocortisone (Sigma) and bovine pituitary extract (Kurabo, Osaka, Japan). All nine patients were H. Nakamura et al. 
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We performed the immunofluorescence studies as described (15). Briefly, SGECs cultured on 12-mm 2 cover slips were fixed in phosphate-buffered saline (PBS) containing 4% paraformaldehyde at 4°C, followed by immersion in methanol at −20°C for 10 min. After fixation, the SGECs were blocked in 5% normal horse serum in PBS, and then incubated in the primary antibodies for 1 h 
Cytokine dot-blot array analysis for co-cultured supernatant
We used a cytokine dot-blot array system used according to the manufacturer's instructions (Proteome Profiler™, the human cytokine array panel A array kit, R&D Systems, Minneapolis, MN). Briefly, we incubated diluted co-cultured supernatant with a cocktail of biotinylated antibodies for 1 h after the membranes were blocked. The mixture of cytokines/chemokines and antibodies was then H. Nakamura et al.
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incubated for 2 h with this array system, which was combined with an immobilized antibody on the membrane. For the detection of cytokines and chemokines, chemiluminescent reagents were used after incubation with streptavidin-horseradish peroxidase. The expressions are noted as the ratio compared with control dot-blots.
Apoptosis dot-blot array analysis for co-cultured lysate
We used an apoptosis dot-blot array system used according to the manufacturer's instructions (Proteome Profiler™, the human apoptosis array kit, R&D Systems, Minneapolis, MN). Briefly, diluted co-cultured cellular extracts were incubated on membranes for 2 h after the membranes were blocked for 1 h. After a 2-h incubation, a cocktail of biotinylated antibodies was added to the membranes and incubated for 1 h. Chemiluminescent reagents were then used after incubation with streptavidin-horseradish peroxidase for 30 min. The expressions are noted as the ratio compared with control dot-blots.
Cytokine and chemokine assay for co-cultured supernatant by ELISA
The ELISA system was used according to the manufacturer's instructions, and the levels of sICAM-1, CXCL10/IP-10, CCR5/RANTES, CXCL1/GROα and CXCL8/IL-8 were measured (all from R&D Systems). Briefly, the assigned volume of the cell culture supernatant, standard or control was added to an ELISA well and incubated for the indicated times. After the wells were washed and decanted three times, each conjugate was added to a well and incubated for 1 h at 4°C. After the washing process, substrate solution was added to each well and incubated for 15 min. After the addition of stop solution, optical density at 450 nm was measured.
In situ PCR of HTLV-I proviral DNA in the co-cultured SGECs
Initially, SGECs co-cultured with or without HCT-5 were fixed in 0.5 mL Carnoy's fixative for 20 min at room temperature, followed by washing with 0.5 mL 70% ethanol for 15 min at room temperature on type I collagen-coated 12-mm 2 cover slips. After treatment with pre-warmed protein kinase (PK) (1 µg/mL) at 37°C for 15 min and three washes with PBS, the SGECs were fixed with 4% PFA/PBS for 5 min, then immersed in 50% formamide/2× saline sodium citrate buffer (SSC) at 4°C overnight. After being washed with deuterium-depleted water (DDW) three times for 5 min each time, the cells were H. Nakamura et al. Middlesex, UK). The details of the in situ PCR reaction were as follows: each block was heated at 92°C for 3 min, and then five cycles of PCR were performed (92°C, 1 min; 47°C, 1 min; 70°C, 2 min), and the block was then held at 70°C for 5 min. The reacted cover slips were then washed with 2×SSC at 37°C for 15 min, four times, followed by washing with 0.5×SSC at 45°C for 15 min, two times.
After the cover slips were reacted with PBS once and covered with Vectashield mounting medium, we visualized the SGECs by the fluorochrome with the fluorescence microscope (BIOREVO BZ-9000).
Statistical analysis
Differences in the ELISA results were analyzed using Student's t-test. P-values <0.05 were accepted as significant.
RESULTS
The phenotype and viability of HCT-5 cells
We found that the HCT-5 cells used for co-culture with SGECs showed the CD4 + phenotype (Fig. 1A) without staining for CD8 and CD20. The HCT-5 cells were viable with translocation of NF-κB into the nucleus in co-culture medium (i.e., the defined keratinocyte-SFM) for SGECs for 0-96 h (Fig. 1B) .
Detection of HTLV-I-related proteins in SGECs during co-culture
After the co-culture of SGECs and HCT-5 cells, immunofluorescence demonstrated the clear signals of HTLV-I proteins p19, p28 and GAG emerged at 72-96 h (Fig. 2A) . In the low-magnification view at 96h co-culture of SGECs with HCT-5 cells, approx. 10% of the SGECs showed HTLV-I-positive staining H. Nakamura et al.
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( Fig. 2B) . Nuclear NF-κB p65 was also detected among 10% of the SGECs after co-culture ( Fig. 2A, B) . To distinguish HTLV-I-infected SGECs from HCT-5, SGECs were stained with cytokeratin 8/18 (Fig. 2C ) that was reported to be one of markers for SGECs (18). In merged view, frequency of HTLV-I-infected
SGECs was calculated as 7.8 ± 1.3 % and the remaining HCT-5 cells were observed during 48-96 h co-culture.
Detection of HTLV-I DNA in SGECs by in situ PCR
To investigate the details and confirm whether HTLV-I infected the SGECs during co-culture with HCT-5 cells, we determined the HTLV-I DNA expression. The dot-blot data were confirmed by immunofluorescence and ELISA.
As shown in Figure 5A , 5B ). Accordingly, significant increases of sICAM-1, RANTES, and IP-10 in the co-cultured supernatant compared to before the co-culture was confirmed by ELISA (Fig. 5C ). However, in SGECs/Jurkat co-culture supernatant, significant increase of sICAM-1, RANTES, and IP-10 was not observed (Fig. 5D) . (Fig. 6B) .
Detection of no apoptosis of co-cultured SGECs
We have reported that cultured SGECs are committed to apoptosis by several stimuli (15, 16). Since in the present study we found that the expression of pro-apoptotic molecules was increased by co-culture with HCT-5 cells, it could be speculated that the co-culture with HCT-5 cells might induce apoptosis of SGECs. As we showed previously, the SGECs stimulated with TRAIL showed clear increases of TUNEL-positive cells (Fig. 6C, positive control) . In contrast, during the 0 to 96 h co-culture, no TUNEL-positive staining was observed in the SGECs during co-culture with HCT-5 cells (Fig. 6C) . In addition, no obvious morphological change was observed on the bright field views during co-culture.
Similarly, no TUNEL positive staining was observed in the SGECs during the 0 to 96 h co-culture with Jurkat (Fig. 6D) .
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DISCUSSION
With regard to the relationship between pSS and retrovirus, Talal et al. first
reported that serum antibodies against human immunodeficiency virus (HIV)-1
were detected in 30% of sera from patients with pSS (19), and the presence of retroviral particles was reported in salivary tissues from patients with SS (20).
The retroviral particles were also found in LSGs from patients with SS (21). 
Regarding HTLV-I infection in pSS,
